welcome to cyprotex
home > investor relations > shareholder information

Shareholder Information

Investor Enquiries
Dr. Anthony Baxter - Chief Executive Officer
Mark Warburton - Company Secretary
Cyprotex PLC
15 Beech Lane
Macclesfield
Cheshire
SK10 2DR
Contact : Dr. Anthony Baxter (T) +44 (0)1625 505 100
Contact : Mark Warburton (T) +44 (0)1625 505 117
e-mail : ir@cyprotex.com

Advisor Contacts

Nominated Advisor
Singer Capital Markets Limited
One Hanover Street
London
W1S 1YZ
Contact : Shaun Dobson / Claes Spång (T) +44 203 205 7500

Stockbroker
Singer Capital Markets Limited
One Hanover Street
London
W1S 1YZ
Contact : Shaun Dobson / Claes Spång (T) +44(0) 203 205 7500

Auditor
Ernst & Young LLP
100 Barbirolli Square
Manchester
M2 3EY
Contact : Alastair Nuttall (T) +44(0)161 333 3000

Financial PR Advisors
Financial Dynamics
Holborn Gate
26 Southampton Buildings
London
WC2A 1PB
Contact : Ben Brewerton / John Dineen (T) +44 (0)20 7831 3113
e-mail : cyprotex@fd.com

Registered Office
100 Barbirolli Square
Manchester
M2 3AB

Registrars
Capita Registrars Ltd
Northern House
Woodsome park
Fenay Bridge
Huddersfield HD8 0LA
www.capita-irg.com

Telephone contact:
If calling from the UK: 0871 664 0300*
*Calls cost 10p per minute plus network extras,
lines are open 8.30am - 5.30pm Mon-Fri.
If calling from overseas: +44 208 639 3399.

contact

Find out more about us.

Investor Relations
Anthony Baxter/Mark Warburton

Call on +44 1625 505100

contact
careerscontactlegalprivacy
This website was last updated
on 31st August 2010
This website is intended to assist investors, industry participants, customers and employees to understand Cyprotex’s global operations and ambitions.
Certain information and detail is disclosed in the interest of compliance of AIM Rule 26.